Announcements Trials

Browse Landscape

Status

Active not recruiting 4 Completed 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Radiation Injuries 1 Multiple Myeloma 1 Multiple Chronic Conditions 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 76 Docetaxel 69 Capecitabine 64 Trastuzumab 61 Paclitaxel 50 Tamoxifen 46 Epirubicin 46 Letrozole 42 pyrotinib 40 Fulvestrant 36 Doxorubicin 35 Vinorelbine 33 Radiotherapy 32 Carboplatin 31 exemestane 27 Anastrozole 27 Neoadjuvant Therapy 24 Drug Therapy 22 Fluorouracil 21 palbociclib 20 Exercise 19 Chemotherapy, Adjuvant 19 Bevacizumab 18 pertuzumab 16 Goserelin 16 Cisplatin 16 liposomal doxorubicin 15 Mammography 14 Gemcitabine 14 Blood Specimen Collection 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasms × Patient Reported Outcome Measures × Clear all

NCT02304614 2020-10-22

3DBCT

Royal Marsden NHS Foundation Trust

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡